Owkin operates as an artificial intelligence (AI)-based biotechnology company. It utilizes AI to enhance the process of finding suitable treatments for patients. The company's main services include the use of AI to identify new treatments, accelerate clinical trials, and build diagnostic tools. It enables researchers in hospitals, universities, and the biopharmaceutical industry to understand how drug efficacy varies for the improvement of drug development. Its services primarily cater to the biopharmaceutical and academic research sectors. It was founded in 2016 and is based in New York, New York.

Datavant operates as a company focused on health data connectivity in the healthcare industry. It offers services that securely and compliantly connect patient-level health data, providing solutions for data and analytics, life sciences, providers, government agencies, research networks, and health plans. Its primary customers are organizations within the healthcare sector. The company was founded in 2017 and is based in San Francisco, California.

MDClone operates as a company focused on healthcare data analytics. It offers a self-service data analytics platform that enables healthcare collaboration, research, and innovation. The company primarily serves the healthcare industry. It was founded in 2015 and is based in Beer-Sheva, Israel.

MediMergent is a data collection and analytics company operating in the healthcare sector. The company's main services include the collection and analysis of real-world evidence, with a focus on capturing and utilizing the voice of the patient. MediMergent primarily serves pharmaceutical and life science companies, health insurers and payers, and data analytics aggregators. It was founded in 2014 and is based in Rockville, Maryland.

Verantos is a company that focuses on generating high-validity real-world evidence in the life sciences sector. The company offers a platform that integrates various real-world data sources and uses artificial intelligence to generate evidence with high accuracy, completeness, and traceability. This evidence is used to accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas. It was founded in 2015 and is based in Menlo Park, California.

ConcertAI is a leader in clinical artificial intelligence and real-world data products within the healthcare sector. The company offers a suite of AI-driven solutions and services designed to optimize clinical trials, provide predictive patient insights, and support commercial healthcare solutions. ConcertAI primarily serves the oncology research and clinical development sectors. It was founded in 2017 and is based in Cambridge, Massachusetts.